Suppr超能文献

新型冠状病毒肺炎相关新发糖尿病:多器官损伤及新型冠状病毒感染死亡的早期指标

New-onset COVID-19-related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection.

作者信息

Yang Jin-Kui, Zhao Miao-Miao, Jin Jian-Min, Liu Shi, Bai Peng, He Wei, Wu Fei, Liu Xiao-Fang, Chai Zhong-Lin, Han De-Min

机构信息

Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.

Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.

出版信息

Curr Med (Cham). 2022;1(1):6. doi: 10.1007/s44194-022-00006-x. Epub 2022 May 26.

Abstract

OBJECTIVE

The pandemic of 2019 coronavirus (SARS-CoV-2) disease (COVID-19) has imposed a severe public health burden worldwide. Most patients with COVID-19 were mild. Severe patients progressed rapidly to critical condition including acute respiratory distress syndrome (ARDS), multi-organ failure and even death. This study aims to find early multi-organ injury indicators and blood glucose for predicting mortality of COVID-19.

METHODS

Fasting blood glucose (FBG) ≥7.0 mmol/L for two times during hospitalization and without a history of diabetes were defined as new-onset COVID-19-related diabetes (CRD). Indicators of injuries for multiple organs, including the lung, heart, kidney and liver, and glucose homeostasis were specifically analyzed for predicting death.

RESULTS

A total of 120 patients with a severity equal to or greater than were hospitalized. After excluding patients with history of diabetes, chronic heart, kidney, and liver disease, 69 patients were included in the final analysis. Of the 69 patients, 23 were , 20 were , and 26 were (including 16 deceased patients). Univariable analysis indicated that CRD, lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBDH), creatine kinase (CK) and creatinine (Cr) were associated with death. Multivariable analysis indicated that CRD was an independent predictor for death (HR = 3.75, 95% CI 1.26-11.15). Abnormal glucose homeostasis or CRD occurred earlier than other indicators for predicting poor outcomes. Indicators of multiple organ injury were in parallel with the expression patterns of ACE2 (the SARS-CoV-2 receptor) in different organs including pancreatic islet.

CONCLUSIONS

New-onset COVID-19-related diabetes is an early indicator of multi-organ injury and predictor for poor outcomes and death in COVID-19 patients. As it is easy to perform for clinical practices and self-monitoring, glucose testing will be helpful for predicting poor outcomes to facilitate appropriate intensive care.

摘要

目的

2019冠状病毒(SARS-CoV-2)疾病(COVID-19)大流行给全球带来了严重的公共卫生负担。大多数COVID-19患者症状较轻。重症患者会迅速发展为危重症,包括急性呼吸窘迫综合征(ARDS)、多器官功能衰竭甚至死亡。本研究旨在寻找早期多器官损伤指标和血糖以预测COVID-19患者的死亡率。

方法

住院期间空腹血糖(FBG)≥7.0 mmol/L且无糖尿病病史者被定义为新发COVID-19相关糖尿病(CRD)。具体分析了包括肺、心、肾和肝在内的多个器官的损伤指标以及葡萄糖稳态指标以预测死亡情况。

结果

共收治了120例病情严重程度为……及以上的患者。排除有糖尿病病史、慢性心、肾和肝病患者后,最终纳入69例患者进行分析。这69例患者中,23例为……,20例为……,26例为……(包括16例死亡患者)。单因素分析表明,CRD、乳酸脱氢酶(LDH)、羟丁酸脱氢酶(HBDH)、肌酸激酶(CK)和肌酐(Cr)与死亡相关。多因素分析表明,CRD是死亡的独立预测因素(HR = 3.75,95%CI 1.26 - 11.15)。异常葡萄糖稳态或CRD比其他预测不良预后的指标出现更早。多器官损伤指标与包括胰岛在内的不同器官中ACE2(SARS-CoV-2受体)的表达模式平行。

结论

新发COVID-19相关糖尿病是多器官损伤的早期指标,也是COVID-19患者不良预后和死亡的预测因素。由于血糖检测在临床实践和自我监测中易于操作,它将有助于预测不良预后,以便进行适当的重症监护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9132601/4d65ac51e6ea/44194_2022_6_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验